Daily FNArena News

Weekly Update on ASX-listed companies buying in their own stock.

Peter Switzer of the Switzer Super Report argues why he believes the latest down-leg for the Australian market is a buying opportunity.

Westpac will focus on customer service and productivity going forward. Brokers welcome the extra clarity on the outlook but suspect some of the goals may be tough to achieve.

Picking well funded explorers; oil price strain apparent; reviewing iron ore break-even prices; zinc deficit continues; gold doldrums.

Gold projects remain hotly contested in Australia, whether it be via takeover, joint venture or further exploration. Two companies at different stages of growth provoke broker interest.

Michael Gable of Fairmont Equities suggests M2 Group is one stock set to find support after the market sell-off.

To reflect current market conditions, TradeTech last week increased its spot and mid-term weekly price indicators while reducing its long-term indicator.

Further negative news has been forthcoming from ResMed’s SERVE-HF trial which has disappointed brokers.

Occupancy at Mantra Group’s resorts continues to improve and brokers believe the weak local currency is supporting a buoyant outlook.

Nick Linton-Ffrost of Fifth Wave suggests what happens in the next week will determine whether the correction for the ASX200 is complete or whether there’s a lot more downside to come.